Wendy’s/Arby’s Group, Inc. (NYSE:WEN) has regained momentum in regards to its comp growth due to preannounced Q2 same store sales, according to Cowen. The firm thinks stock ownership may moved from “value investors” to “growth at a reasonable price” investors and that shares show compelling valuation. Share have an Outperform rating.
Don’t Miss: Get Ready For Another Apple Software SURPRISE.
Cliffs Natural Resources Inc. (NYSE:CLF) estimates were lowered by Morgan Stanley due to forecasts for reduced iron ore prices. the firm also states that capect and project execution are still overhangs. The shares possess an Equal Weight rating.
Wageworks Inc (NYSE:WAGE) price target was raised following channel checks indicating strong new customer activity. The firm maintains a Buy rating on shares.
Orexigen Therapeutics, Inc. (NASDAQ:OREX): Following the FDA approval of Orexigen competitor Arena Pharmaceuticals’ (NASDAQ:ARNA) anti-obesity drug, JMP Securities predicts that Orexigen may benefit from the agency’s opinion. The firm believes there are a number of positive catalysts for Orexigen’s drug and believes that Orexigen gives the best anti-obesity value. JMP Securities keeps an Outperform rating on the shares.
Riverbed Technology, Inc. (NASDAQ:RVBD) target was lowered by JMP Securities due to a challenging economic environment and what the firm views as a higher than average company sales organization turnovers. On the other hand, the firm predicts taht the company could keep gaining market share in the long run keeping the shares at an Outperform rating.
Don’t Miss: Arena Shares Skyrocket and Sink on EPIC Victory.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.